Dennis
Scanlon
Distinguished Professor of Health Policy and Administration
Expertise:
- Health & Medicine
Focus Areas:
- Health Policy
In The Media:
About
- Dennis Scanlon is available to broadly comment on topics such as COVID-19 vaccine policy and regulation, the need for a centralized health data system for supporting research and treatment of COVID-19, and the role of institutions and individual health care providers in improving patient outcomes.
Dennis Scanlon is a Distinguished Professor of Health Policy and Administration and the director of the Center for Health Care and Policy Research. Scanlon’s research focuses on the role of quality improvement and incentives in changing healthcare outcomes such as clinical quality, patient experience, and economic efficiency.
During the COVID-19 pandemic, Scanlon has been providing public commentary on the regulatory process in the United States for testing the COVID-19 vaccine candidates to determine their efficacy and effectiveness and on how an Emergency Use Authorization can help speed up the approval for expedited distribution to the population. He has also commented on the ethical issues and other potential challenges faced in distributing a limited vaccine supply in the United States and globally.
In The Media
College Revenues Shrinking During Coronavirus Pandemic
from VOA News October 14, 2020
“No matter how you slice it, there's uncertainty, and there are costs and benefit trade-offs. That sounds perhaps to some a little bit crass, but really trying to weigh the risk, what level of risk may be worth taking, and what are the costs to mitigate that risk."
While UPMC and Highmark squared off, national players moved into the Medicare Advantage market
from Pittsburgh Post-Gazette October 28, 2019